A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection
Biotechnology and Bioengineering · 2023
DOI: 10.1002/bit.28422 ↗At a glance
Journal article in Biotechnology and Bioengineering, 2023. Written by Wakana Sato and 7 co-authors. Institution: Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA. Major MEDLINE topics: Protein Biosynthesis, Artificial Cells. Cited 5 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Aeronautics and Space Administration.
Abstract (original language)
Synthetic cells, expressing proteins using cell‐free transcription‐translation (TXTL), is a technology utilized for a variety of applications, such as investigating natural gene pathways, metabolic engineering, drug development or bioinformatics. For all these purposes, the ability to precisely control gene expression is essential. Various strategies to control gene expression in TXTL have been developed; however, further advancements on gene‐specific and straightforward regulation methods are still needed. Here, we present a method of control of gene expression in TXTL using a “silencing oligo”: a short oligonucleotide, designed with a particular secondary structure, that binds to the target messenger RNA. We demonstrated that silencing oligo inhibits protein expression in TXTL in a sequence‐dependent manner. We showed that silencing oligo activity is associated with RNase H activity in bacterial TXTL. To complete the gene expression control toolbox for synthetic cells, we also engineered a first transfection system. We demonstrated the transfection of various payloads, enabling the introduction of RNA and DNA of different lengths to synthetic cell liposomes. Finally, we combined the silencing oligo and the transfection technologies, demonstrating control of gene expression by transfecting silencing oligo into synthetic minimal cells.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, USA.
ORCID profiles: Katarzyna P Adamala
Funding
- National Aeronautics and Space Administration
Cite
APA
Sato, W., Rasmussen, M., Gaut, N., Devarajan, M., Stokes, K., Deich, C., Engelhart, A. E., & Adamala, K. P. (2023). A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28422
Vancouver
Sato W, Rasmussen M, Gaut N, Devarajan M, Stokes K, Deich C, et al. A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection. Biotechnology and Bioengineering. 2023. doi:10.1002/bit.28422
BibTeX
@article{Sato2023,
author = {Sato, Wakana and Rasmussen, Melanie and Gaut, Nathaniel and Devarajan, Mahima and Stokes, Kaitlin and Deich, Christopher and Engelhart, Aaron E and Adamala, Katarzyna P},
title = {A gene expression control technology for cell‐free systems and synthetic cells via targeted gene silencing and transfection},
journal = {Biotechnology and Bioengineering},
year = {2023},
doi = {10.1002/bit.28422}
}
EUVIMED